Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.410
-0.100 (-6.62%)
May 13, 2025, 4:00 PM - Market closed
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
$246,613
Profits / Employee
-$272,667
Market Cap
107.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CLLS News
- 1 day ago - Cellectis Reports Financial Results for the First Quarter 2025 - GlobeNewsWire
- 7 days ago - Cellectis to Report First Quarter Financial Results on May 12, 2025 - GlobeNewsWire
- 15 days ago - Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting - GlobeNewsWire
- 2 months ago - Cellectis S.A. (CLLS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update - GlobeNewsWire
- 2 months ago - Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025 - GlobeNewsWire
- 2 months ago - Cellectis Presents ‘Smart CAR T' Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025 - GlobeNewsWire
- 5 months ago - Cellectis: Poised To Start Answering Questions In 2025 - Seeking Alpha